348 related articles for article (PubMed ID: 37498674)
1. Genetic modification of inflammation- and clonal hematopoiesis-associated cardiovascular risk.
Yu Z; Fidler TP; Ruan Y; Vlasschaert C; Nakao T; Uddin MM; Mack T; Niroula A; Heimlich JB; Zekavat SM; Gibson CJ; Griffin GK; Wang Y; Peloso GM; Heard-Costa N; Levy D; Vasan RS; Aguet F; Ardlie KG; Taylor KD; Rich SS; Rotter JI; Libby P; Jaiswal S; Ebert BL; Bick AG; Tall AR; Natarajan P
J Clin Invest; 2023 Sep; 133(18):. PubMed ID: 37498674
[TBL] [Abstract][Full Text] [Related]
2. Clonal hematopoiesis and associated diseases: A review of recent findings.
Asada S; Kitamura T
Cancer Sci; 2021 Oct; 112(10):3962-3971. PubMed ID: 34328684
[TBL] [Abstract][Full Text] [Related]
3. Somatic Mutations and Clonal Hematopoiesis as Drivers of Age-Related Cardiovascular Risk.
Haring B; Wissel S; Manson JE
Curr Cardiol Rep; 2022 Aug; 24(8):1049-1058. PubMed ID: 35657494
[TBL] [Abstract][Full Text] [Related]
4. Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease.
Gumuser ED; Schuermans A; Cho SMJ; Sporn ZA; Uddin MM; Paruchuri K; Nakao T; Yu Z; Haidermota S; Hornsby W; Weeks LD; Niroula A; Jaiswal S; Libby P; Ebert BL; Bick AG; Natarajan P; Honigberg MC
J Am Coll Cardiol; 2023 May; 81(20):1996-2009. PubMed ID: 37197843
[TBL] [Abstract][Full Text] [Related]
5. Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions.
Singh I; Singh A
Curr Oncol Rep; 2023 Jun; 25(6):539-547. PubMed ID: 36928826
[TBL] [Abstract][Full Text] [Related]
6. Clonal hematopoiesis of indeterminate potential (CHIP): Linking somatic mutations, hematopoiesis, chronic inflammation and cardiovascular disease.
Marnell CS; Bick A; Natarajan P
J Mol Cell Cardiol; 2021 Dec; 161():98-105. PubMed ID: 34298011
[TBL] [Abstract][Full Text] [Related]
7. Supplemental Association of Clonal Hematopoiesis With Incident Heart Failure.
Yu B; Roberts MB; Raffield LM; Zekavat SM; Nguyen NQH; Biggs ML; Brown MR; Griffin G; Desai P; Correa A; Morrison AC; Shah AM; Niroula A; Uddin MM; Honigberg MC; Ebert BL; Psaty BM; Whitsel EA; Manson JE; Kooperberg C; Bick AG; Ballantyne CM; Reiner AP; Natarajan P; Eaton CB;
J Am Coll Cardiol; 2021 Jul; 78(1):42-52. PubMed ID: 34210413
[TBL] [Abstract][Full Text] [Related]
8. Obesity-induced inflammation exacerbates clonal hematopoiesis.
Pasupuleti SK; Ramdas B; Burns SS; Palam LR; Kanumuri R; Kumar R; Pandhiri TR; Dave UP; Yellapu NK; Zhou X; Zhang C; Sandusky GE; Yu Z; Honigberg MC; Bick AG; Griffin GK; Niroula A; Ebert BL; Paczesny S; Natarajan P; Kapur R
J Clin Invest; 2023 Jun; 133(11):. PubMed ID: 37071471
[TBL] [Abstract][Full Text] [Related]
9. Association of Clonal Hematopoiesis of Indeterminate Potential With Inflammatory Gene Expression in Patients With Severe Degenerative Aortic Valve Stenosis or Chronic Postischemic Heart Failure.
Abplanalp WT; Mas-Peiro S; Cremer S; John D; Dimmeler S; Zeiher AM
JAMA Cardiol; 2020 Oct; 5(10):1170-1175. PubMed ID: 32639511
[TBL] [Abstract][Full Text] [Related]
10. Clonal Hematopoiesis of Indeterminate Potential With Loss of
Lin AE; Bapat AC; Xiao L; Niroula A; Ye J; Wong WJ; Agrawal M; Farady CJ; Boettcher A; Hergott CB; McConkey M; Flores-Bringas P; Shkolnik V; Bick AG; Milan D; Natarajan P; Libby P; Ellinor PT; Ebert BL
Circulation; 2024 Apr; 149(18):1419-1434. PubMed ID: 38357791
[TBL] [Abstract][Full Text] [Related]
11. Clonal hematopoiesis of indeterminate potential (CHIP) and cardiovascular diseases-an updated systematic review.
Senguttuvan NB; Subramanian V; Venkatesan V; Muralidharan TR; Sankaranarayanan K
J Genet Eng Biotechnol; 2021 Jul; 19(1):105. PubMed ID: 34279740
[TBL] [Abstract][Full Text] [Related]
12. Clonal hematopoiesis and cardiovascular disease: deciphering interconnections.
Stein A; Metzeler K; Kubasch AS; Rommel KP; Desch S; Buettner P; Rosolowski M; Cross M; Platzbecker U; Thiele H
Basic Res Cardiol; 2022 Nov; 117(1):55. PubMed ID: 36355225
[TBL] [Abstract][Full Text] [Related]
13. Telomere Attrition and Clonal Hematopoiesis of Indeterminate Potential in Cardiovascular Disease.
Huang YC; Wang CY
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576030
[TBL] [Abstract][Full Text] [Related]
14. A new risk factor associated with cardiovascular disease: clonal hematopoiesis of indeterminate potential.
Yu X; Qian N; Wang Y
Mol Biol Rep; 2023 Mar; 50(3):2813-2822. PubMed ID: 36595120
[TBL] [Abstract][Full Text] [Related]
15. Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease.
Jaiswal S; Natarajan P; Silver AJ; Gibson CJ; Bick AG; Shvartz E; McConkey M; Gupta N; Gabriel S; Ardissino D; Baber U; Mehran R; Fuster V; Danesh J; Frossard P; Saleheen D; Melander O; Sukhova GK; Neuberg D; Libby P; Kathiresan S; Ebert BL
N Engl J Med; 2017 Jul; 377(2):111-121. PubMed ID: 28636844
[TBL] [Abstract][Full Text] [Related]
16. Genetic Interleukin 6 Signaling Deficiency Attenuates Cardiovascular Risk in Clonal Hematopoiesis.
Bick AG; Pirruccello JP; Griffin GK; Gupta N; Gabriel S; Saleheen D; Libby P; Kathiresan S; Natarajan P
Circulation; 2020 Jan; 141(2):124-131. PubMed ID: 31707836
[TBL] [Abstract][Full Text] [Related]
17. Clinical consequences of clonal hematopoiesis of indeterminate potential.
Steensma DP
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):264-269. PubMed ID: 30504320
[TBL] [Abstract][Full Text] [Related]
18. Clonal hematopoiesis: Genes and underlying mechanisms in cardiovascular disease development.
Haybar H; Shahrabi S; Ghanavat M; Khodadi E
J Cell Physiol; 2019 Jun; 234(6):8396-8401. PubMed ID: 30417440
[TBL] [Abstract][Full Text] [Related]
19. Nonpreferential but Detrimental Accumulation of Macrophages With Clonal Hematopoiesis-Driver Mutations in Cardiovascular Tissues-Brief Report.
Dederichs TS; Yerdenova A; Horstmann H; Vico TA; Nübling S; Peyronnet R; Pfeifer D; von Zur Muehlen C; Heidt T; Wolf D; Czerny M; Westermann D; Hilgendorf I
Arterioscler Thromb Vasc Biol; 2024 Mar; 44(3):690-697. PubMed ID: 38269586
[TBL] [Abstract][Full Text] [Related]
20. Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Incident Type 2 Diabetes Risk.
Tobias DK; Manning AK; Wessel J; Raghavan S; Westerman KE; Bick AG; Dicorpo D; Whitsel EA; Collins J; Correa A; Cupples LA; Dupuis J; Goodarzi MO; Guo X; Howard B; Lange LA; Liu S; Raffield LM; Reiner AP; Rich SS; Taylor KD; Tinker L; Wilson JG; Wu P; Carson AP; Vasan RS; Fornage M; Psaty BM; Kooperberg C; Rotter JI; Meigs J; Manson JE;
Diabetes Care; 2023 Nov; 46(11):1978-1985. PubMed ID: 37756531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
